Company / Shares Outstanding
Lipocine Inc. Shares Outstanding History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
5.3M
FY2025
5-year range
5.2M / 88.3M
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 5234830.00 to 5347940.00 over the past 2 years.
Based on SEC 10-K filings.
5347940.00 in FY2025 with a 5-year CAGR of -32.3%.
Increased from 5234830.00 to 5347940.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -60.7%
- 5-Year CAGR
- -32.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.6% year-over-year.
- Peak shares outstanding was recorded in FY2022.
- Lowest shares outstanding in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.3M | +0.6% |
| FY2024 | 5.3M | +1.5% |
| FY2023 | 5.2M | -94.1% |
| FY2022 | 88.3M | +26.1% |
| FY2021 | 70.0M | +86.0% |
| FY2020 | 37.6M | +73.2% |
| FY2019 | 21.7M | +2.2% |
| FY2018 | 21.3M | +377.2% |
| FY2013 | 4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026